These findings provide evidence that reduction in PAD4 expression and citrullination correspond with delayed retinal degeneration, highlighting the potential therapeutic benefits of SF3 in retinal disease pertaining to autoimmunity. The gene discussed is PADI4; the disease is retinal degeneration.